Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 409

The DOI matches its Crossref record.

Proliferative Vitreoretinopathy

Pastor, J.Carlos·1998·Survey of Ophthalmology
DOI 10.1016/s0039-6257(98)00023-x
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0039-6257(98)00023-x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 130

  1. Aguirrebeña, 1986, Incidencia de la vitreorretinopatı́a proliferante (VRP) en el desprendimiento de retina regmatógeno, Arch Soc Esp Oftalmol, 51, 229
  2. Algvere, 1992, Results of pneumatic retinopexy with air, Acta Ophthalmol, 70, 632, 10.1111/j.1755-3768.1992.tb02144.x · doi:10.1111/j.1755-3768.1992.tb02144.x
  3. Alturki, 1992, Posterior relaxing retinotomies, Ophthalmic Surg, 23, 685
  4. Araiz, 1993, Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy, Invest Ophthalmol Vis Sci, 34, 522
  5. Arroyo, 1993, Silicone oil as a delivery vehicle for BCNU in rabbit proliferative vitreoretinopathy, Retina, 13, 245, 10.1097/00006982-199313030-00011 · doi:10.1097/00006982-199313030-00011
  6. Baudouin, 1991, Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy, Invest Ophthalmol Vis Sci, 32, 2065
  7. Baudouin, 1990, Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy, Am J Ophthalmol, 110, 593, 10.1016/S0002-9394(14)77054-0 · doi:10.1016/s0002-9394(14)77054-0
  8. Berger, 1996, Intravitreal sustained release corticosteroid-5-fluorouracil conjugate in the treatment of experimental proliferative vitreoretinopathy, Invest Ophthalmol Vis Sci, 37, 2318
  9. Berman, 1989, Proliferative vitreoretinopathy, Ophthalmic Surg, 20, 268
  10. Binder, 1994, Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study, Graefes Arch Clin Exp Ophthalmol, 232, 211, 10.1007/BF00184007 · doi:10.1007/bf00184007
  11. Blumenkranz, 1993, Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 5, Am J Ophthalmol, 116, 557, 10.1016/S0002-9394(14)73196-4 · doi:10.1016/s0002-9394(14)73196-4
  12. Blumenkranz, 1984, 5-Fluorouracil, Ophthalmology, 91, 122, 10.1016/S0161-6420(84)34318-4 · DOI · Paper page
  13. Blumenkranz, 1982, Fluorouracil for the treatment of massive periretinal proliferation, Am J Ophthalmol, 94, 458, 10.1016/0002-9394(82)90239-2 · DOI · Paper page
  14. Bonnet, 1994, Macular changes and fluorescein angiographic findings after repair of proliferative vitreoretinopathy, Retina, 14, 404, 10.1097/00006982-199414050-00003 · doi:10.1097/00006982-199414050-00003
  15. Bonnet, 1984, Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment, Ophthalmologica (Basel), 188, 148, 10.1159/000309357 · doi:10.1159/000309357
  16. Bonnet, 1995, Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR, Graefes Arch Clin Exp Ophthalmol, 233, 789, 10.1007/BF00184091 · doi:10.1007/bf00184091
  17. Bourke, 1996, Vascular consequences of retinectomy, Arch Ophthalmol, 114, 155, 10.1001/archopht.1996.01100130149006 · doi:10.1001/archopht.1996.01100130149006
  18. Broekhuyse, 1990, Autoimmune responsiveness to retinal IRBP, S-antigen and opsin in proliferative vitreoretinopathy, Exp Eye Res, 50, 197, 10.1016/0014-4835(90)90231-I · doi:10.1016/0014-4835(90)90231-i
  19. Campochiaro, 1986, Intravitreal chemotactic and mitogenic activity, Arch Ophthalmol, 104, 1685, 10.1001/archopht.1986.01050230123046 · doi:10.1001/archopht.1986.01050230123046
  20. Campochiaro, 1985, Platelet derived growth factor is chemotactic for human retinal pigmented epithelial cells, Arch Ophthalmol, 103, 576, 10.1001/archopht.1985.01050040118034 · DOI · Paper page
  21. Campochiaro, 1984, Serum contains chemoattractants for human retinal epithelial cells, Arch Ophthalmol, 102, 1830, 10.1001/archopht.1984.01040031488029 · DOI · Paper page
  22. Casaroli, 1994, The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy, Invest Ophthalmol Vis Sci, 35, 2791
  23. Chandler, 1987, Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment, Graefes Arch Clin Exp Ophthalmol, 225, 259, 10.1007/BF02150144 · DOI
  24. Chang, 1987, Low viscosity liquid fluorochemicals in vitreous surgery, Am J Ophthalmol, 103, 38, 10.1016/S0002-9394(14)74166-2 · doi:10.1016/s0002-9394(14)74166-2
  25. Chang, 1989, Giant retinal tears, Arch Ophthalmol, 107, 761, 10.1001/archopht.1989.01070010779046 · doi:10.1001/archopht.1989.01070010779046
  26. Chang, 1987, Experimental vitreous replacement with perfluorotributylamine, Am J Ophthalmol, 103, 29, 10.1016/S0002-9394(14)74165-0 · DOI
  27. Chapman, 1992, The effect of low-molecular-weight heparin on proliferative vitreoretinopathy induced in the rabbit eye (abstract), Invest Ophthalmol Vis Sci, 33, 855
  28. Charteris, 1995, Proliferative vitreoretinopathy, Br J Ophthalmol, 79, 953, 10.1136/bjo.79.10.953 · DOI · Paper page
  29. Charteris, 1992, Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes, Ophthalmology, 99, 1364, 10.1016/S0161-6420(92)31793-2 · DOI
  30. Charteris, 1993, Inflammatory cells in proliferative vitreoretinopathy subretinal membranes, Ophthalmology, 100, 43, 10.1016/S0161-6420(93)31711-2 · DOI
  31. Christmas, 1995, Treatment of retinal breaks with autologous serum in an experimental model, Ophthalmology, 102, 263, 10.1016/S0161-6420(95)31046-9 · DOI
  32. Coleman, 1988, A biologic tissue adhesive for vitreoretinal surgery, Retina, 8, 250, 10.1097/00006982-198808040-00006 · doi:10.1097/00006982-198808040-00006
  33. Cowley, 1989, Clinical risk factors for proliferative vitreoretinopathy, Arch Ophthalmol, 107, 1147, 10.1001/archopht.1989.01070020213027 · DOI · Paper page
  34. Daniels, 1990, Taxol treatment of experimental proliferative vitreoretinopathy, Graefes Arch Clin Exp Ophthalmol, 228, 513, 10.1007/BF00918482 · doi:10.1007/bf00918482
  35. Davis, 1990, Selective inhibition of growing pigment epithelial cells by a receptor-direct immunotoxin, Invest Ophthalmol Vis Sci, 31, 2514
  36. De Juan, 1989, Management of anterior vitreous in proliferative vitreoretinopathy, Retina, 9, 258, 10.1097/00006982-198909040-00003 · doi:10.1097/00006982-198909040-00003
  37. Diddie, 1996, Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10, Ophthalmology, 103, 1092, 10.1016/S0161-6420(96)30562-9 · doi:10.1016/s0161-6420(96)30562-9
  38. Eckardt, 1992, Results of silicone oil removal from eyes treated with retinectomies, Ger J Ophthalmol, 1, 2
  39. Elner, 1995, Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy, Curr Eye Res, 14, 1045, 10.3109/02713689508998529 · DOI · Paper page
  40. Federman, 1990, Extensive peripheral retinectomy combined with posterior 360° retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy cases, Ophthalmology, 97, 1305, 10.1016/S0161-6420(90)32416-8 · doi:10.1016/s0161-6420(90)32416-8
  41. Federman, 1988, Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery, Ophthalmology, 95, 870, 10.1016/S0161-6420(88)33080-0 · doi:10.1016/s0161-6420(88)33080-0
  42. Garcı́a-Layana, 1995, Papel del factor de crecimiento derivado de las plaquetas (PDGF) en un modelo experimental de VRP en el cerdo, Arch Soc Esp Oftalmol, 68, 123
  43. Garcı́a-Layana, 1991, Tratamiento profiláctico de la vitreoretinopatı́a proliferante, Arch Soc Esp Oftalmol, 60, 315
  44. Garcı́a-Layana, 1997, Porcine model of proliferative vitreoretinopathy with platelets, Curr Eye Res, 16, 556, 10.1076/ceyr.16.6.556.5082 · doi:10.1076/ceyr.16.6.556.5082
  45. Gilbert, 1991, Adhesives in retinal detachment surgery, Br J Ophthalmol, 75, 309, 10.1136/bjo.75.5.309 · doi:10.1136/bjo.75.5.309
  46. Girard, 1994, Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery, Retina, 14, 417, 10.1097/00006982-199414050-00005 · doi:10.1097/00006982-199414050-00005
  47. Glaser, 1992, Transforming growth factor-β2 for the treatment of full-thickness macular holes. A prospective randomized study, Ophthalmology, 99, 1162, 10.1016/S0161-6420(92)31837-8 · DOI · Paper page
  48. Glaser, 1993, Cryotherapy during surgery for giant retinal tears and intravitreal dispersion of viable retinal pigment epithelial cells, Ophthalmology, 100, 466, 10.1016/S0161-6420(93)31620-9 · doi:10.1016/s0161-6420(93)31620-9
  49. Goldaracena, 1992, Estudio inmunocitoquı́mico de las membranas perirretinianas en un modelo experimental de vitreoretinopatı́a proliferante (VRP), Arch Soc Esp Oftalmol, 63, 519
  50. Goldaracena, 1997, The role of retinotomy in an experimental model of proliferative vitreoretinopathy, Curr Eye Res, 16, 422, 10.1076/ceyr.16.5.422.7052 · doi:10.1076/ceyr.16.5.422.7052
  51. Goldaracena, 1994, Creación de un modelo eficaz de VRP, Arch Soc Esp Oftalmol, 67, 127
  52. Goldaracena, 1990, Efecto de la inyección intravı́trea de factores plaquetarios asociados a la crioaplicación y su relación con la VRP, Arch Soc Esp Oftalmol (Invest), 3, 161
  53. Gonvers, 1985, Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy, Am J Ophthalmol, 100, 239, 10.1016/0002-9394(85)90788-3 · doi:10.1016/0002-9394(85)90788-3
  54. Gremillion, 1990, Fluorosilicone oil in the treatment of retinal detachment, Br J Ophthalmol, 74, 643, 10.1136/bjo.74.11.643 · doi:10.1136/bjo.74.11.643
  55. Grisanti, 1994, Immune response to specific molecules of the retina in proliferative vitreoretinal disorders, Graefes Arch Clin Exp Ophthalmol, 232, 302, 10.1007/BF00194480 · doi:10.1007/bf00194480
  56. Grisanti, 1993, Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy, Br J Ophthalmol, 77, 238, 10.1136/bjo.77.4.238 · doi:10.1136/bjo.77.4.238
  57. Guerra, 1987, Resultados de las inyecciones de SF6 como tratamiento del desprendimiento de retina, Arch Soc Esp Oftalmol, 53, 393
  58. Hanneken, 1995, Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid, Invest Ophthalmol Vis Sci, 36, 1192
  59. Hart, 1989, Potential antiinflammatory effects of interleukin 4, Proc Natl Acad Sci U S A, 86, 3803, 10.1073/pnas.86.10.3803 · DOI · Paper page
  60. Haut, 1985, Circular subtotal retinectomy and inferior semicircular retinotomy, Ophthalmologica, 191, 65, 10.1159/000309556 · doi:10.1159/000309556
  61. Hermsen, 1990, Long-term inhibition of cellular proliferation by immunotoxins, Arch Ophthalmol, 198, 1009, 10.1001/archopht.1990.01070090111051 · doi:10.1001/archopht.1990.01070090111051
  62. Hernaez, 1990, Estudio experimental de la vitreorretinopatı́a proliferante. Comparación entre dos modelos, Arch Soc Esp Oftalmol, 58, 233
  63. Hiscot, 1984, Retinal pigment epithelial cells in epiretinal membranes, Br J Ophthalmol, 68, 708, 10.1136/bjo.68.10.708 · DOI
  64. Immonen, 1991, Immunohistochemical demonstration of cellular fibronectin and tenascin in human epiretinal membranes, Acta Ophthalmol, 69, 466, 10.1111/j.1755-3768.1991.tb02024.x · DOI
  65. Iverson, 1991, Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy, Arch Ophthalmol, 109, 405, 10.1001/archopht.1991.01080030107048 · doi:10.1001/archopht.1991.01080030107048
  66. Iverson, 1990, Indications and results of relaxing retinotomy, Ophthalmology, 97, 1298, 10.1016/S0161-6420(90)32417-X · doi:10.1016/s0161-6420(90)32417-x
  67. Johnson, 1988, A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin, Ophthalmology, 95, 312, 10.1016/S0161-6420(88)33181-7 · doi:10.1016/s0161-6420(88)33181-7
  68. Johnston, 1988, Immunology, N Engl J Med, 318, 747, 10.1056/NEJM198803243181205 · DOI · Paper page
  69. Koerner, 1982, Postoperative retinal fibrosis—a controlled clinical study of systemic steroid therapy, Graefes Arch Clin Exp Ophthalmol, 219, 268, 10.1007/BF00231411 · doi:10.1007/bf00231411
  70. Kono, 1995, Epiretinal membrane formation. Light and electron microscopic study in an experimental rabbit model, Arch Ophthalmol, 113, 359, 10.1001/archopht.1995.01100030115033 · doi:10.1001/archopht.1995.01100030115033
  71. Kuratsu, 1990, Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitro, J Neurosurg, 73, 436, 10.3171/jns.1990.73.3.0436 · doi:10.3171/jns.1990.73.3.0436
  72. Kuriyama, 1990, Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits, Graefes Arch Clin Exp Ophthalmol, 228, 552, 10.1007/BF00918489 · doi:10.1007/bf00918489
  73. Lazarus, 1992, Histochemical evidence for vitreous hyalocytes as components of pathological vitreous membranes (abstract), Invest Ophthalmol Vis Sci, 33, 58
  74. Lean, 1989, The Silicone Study Group. Classification of proliferative vitreoretinopathy used in the Silicone Study, Ophthalmology, 96, 756, 10.1016/S0161-6420(89)32821-1 · doi:10.1016/s0161-6420(89)32821-1
  75. Ligget, 1995, Human autologous serum for the treatment of full-thickness macular holes, Ophthalmology, 102, 1071, 10.1016/S0161-6420(95)30909-8 · doi:10.1016/s0161-6420(95)30909-8
  76. Limb, 1991, Cytokines in proliferative vitreoretinopathy, Eye, 5, 686, 10.1038/eye.1991.126 · doi:10.1038/eye.1991.126
  77. López, 1989, Análisis experimental de la reacción inflamatoria provocada por las siliconas fluoradas a nivel intraocular, Arch Soc Esp Oftalmol (invest), 2, 149
  78. Lopez, 1992, Long-term results of vitrectomy and perfluorocarbon gas for the treatment of severe proliferative vitreoretinopathy, Am J Ophthalmol, 113, 424, 10.1016/S0002-9394(14)76166-5 · doi:10.1016/s0002-9394(14)76166-5
  79. Lucke, 1987, Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments, Am J Ophthalmol, 104, 624, 10.1016/0002-9394(87)90176-0 · doi:10.1016/0002-9394(87)90176-0
  80. Machemer, 1981, Retinotomy, Am J Ophthalmol, 92, 768, 10.1016/S0002-9394(14)75627-2 · doi:10.1016/s0002-9394(14)75627-2
  81. Machemer, 1978, Pathogenesis and classification of massive periretinal proliferation, Br J Ophthalmol, 62, 737, 10.1136/bjo.62.11.737 · doi:10.1136/bjo.62.11.737
  82. Machemer, 1991, An updated classification of retinal detachment with proliferative vitreoretinopathy, Am J Ophthalmol, 112, 159, 10.1016/S0002-9394(14)76695-4 · DOI · Paper page
  83. Madelcon, 1975, Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants, Am J Ophthalmol, 80, 227, 10.1016/0002-9394(75)90137-3 · DOI
  84. Martini, 1992, Proliferative vitreo-retinal disorders, Acta Ophthalmol, 201, 1
  85. McCuen, 1985, Silicone oil in vitreoretinal surgery, Retina, 5, 198, 10.1097/00006982-198500540-00002 · doi:10.1097/00006982-198500540-00002
  86. McCuen, 1987, Transvitreal cyanoacrylate retinopexy in the management of complicated retinal detachment, Am J Ophthalmol, 104, 127, 10.1016/0002-9394(87)90003-1 · doi:10.1016/0002-9394(87)90003-1
  87. Mietz, 1995, Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseases, Br J Ophthalmol, 79, 874, 10.1136/bjo.79.10.874 · doi:10.1136/bjo.79.10.874
  88. Mietz, 1994, Histopathologic study of epiretinal proliferations after vitrectomy with daunomycin and silicone oil, Retina, 14, 425, 10.1097/00006982-199414050-00006 · doi:10.1097/00006982-199414050-00006
  89. Miller, 1986, Retinal wound healing. Cellular activity at the vitreoretinal interface, Arch Ophthalmol, 104, 281, 10.1001/archopht.1986.01050140139037 · DOI
  90. Miyamoto, 1986, Fluorinated oils as experimental vitreous substitutes, Arch Ophthalmol, 104, 1053, 10.1001/archopht.1986.01050190111048 · doi:10.1001/archopht.1986.01050190111048
  91. Nomoto, 1988, Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine, Atherosclerosis, 72, 213, 10.1016/0021-9150(88)90083-4 · DOI
  92. Ohsato, 1994, Immunohistochemical study of cellular fibronectin in preretinal membranes, Retina, 14, 430, 10.1097/00006982-199414050-00007 · doi:10.1097/00006982-199414050-00007
  93. Ohuchi, 1990, Suppression of human retinal pigment epithelial cell proliferation by hyperthermia, Arch Ophthalmol, 108, 873, 10.1001/archopht.1990.01070080117047 · doi:10.1001/archopht.1990.01070080117047
  94. Olesza, 1988, Inhibition of mitogenic activity of PDGF, EGF and FGF by interferon gamma, Exp Cell Res, 179, 575, 10.1016/0014-4827(88)90295-9 · doi:10.1016/0014-4827(88)90295-9
  95. Pastor, 1992, Intravitreal silicone and fluorosilicone oils, Acta Ophthalmol, 70, 651, 10.1111/j.1755-3768.1992.tb02148.x · doi:10.1111/j.1755-3768.1992.tb02148.x
  96. Piñon, 1992, Intravitreal and subretinal proliferation induced by platelet-rich plasma injection in rabbits, Curr Eye Res, 11, 1047, 10.3109/02713689209015076 · DOI
  97. Piñon, 1991, Estudio experimental del efecto de la inyección intravı́trea de plasma rico en plaquetas asociada a crioaplicación y vitrectomı́a, Arch Soc Esp Oftalmol, 63, 313
  98. Piñon, 1989, Estudio experimental del efecto de la inyección intravı́trea del plasma rico en plaquetas. Resultados preliminares, Arch Soc Esp Oftalmol, 57, 555
  99. Raymond, 1982, Isolation and identification of stimulatory and inhibitory cell growth factors in bovine vitreous, Exp Eye Res, 34, 267, 10.1016/0014-4835(82)90060-4 · DOI
  100. The Retina Society Terminology Committee, 1983, The classification of retinal detachment with proliferative vitreoretinopathy, Ophthalmology, 90, 121, 10.1016/S0161-6420(83)34588-7 · doi:10.1016/s0161-6420(83)34588-7
  101. Ryan, 1993, Traction retinal detachment. XLIX Edward Jackson Memorial Lecture, Am J Ophthalmol, 115, 1, 10.1016/S0002-9394(14)73518-4 · doi:10.1016/s0002-9394(14)73518-4
  102. Ryan, 1985, The pathophysiology of proliferative vitreoretinopathy and its management, Am J Ophthalmol, 100, 188, 10.1016/S0002-9394(14)75004-4 · DOI
  103. Schultz, 1991, Neovascular growth factors, Eye, 5, 170, 10.1038/eye.1991.31 · DOI
  104. Sebag, 1993, Pneumatic retinopexy using only air, Retina, 13, 8, 10.1097/00006982-199313010-00003 · doi:10.1097/00006982-199313010-00003
  105. The Silicone Study Group, 1993, Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4, Ophthalmology, 100, 1629, 10.1016/S0161-6420(93)31425-9 · doi:10.1016/s0161-6420(93)31425-9
  106. The Silicone Study Group: Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3. Retina 13:279–284, 1993 · doi:10.1097/00006982-199313040-00002
  107. The Silicone Study Group: Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol 110:780–792, 1992 · doi:10.1001/archopht.1992.01080180052028
  108. The Silicone Study Group: Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 110:770–779, 1992 · doi:10.1001/archopht.1992.01080180042027
  109. Smiddy, 1989, Transforming growth factor beta. A biologic chorioretinal glue, Arch Ophthalmol, 107, 577, 10.1001/archopht.1989.01070010591036 · DOI
  110. Smith, 1995, Inhibition of proliferative retinopathy using antisense phosphorothioate olignucleotides against vascular endothelial growth factor (VEGF/VPF) (abstract), Invest Ophthalmol Vis Sci, 36, S871
  111. Souza, 1995, Inhibition of experimental proliferative vitreoretinopathy in rabbits by suramin, Ophthalmologica, 209, 211, 10.1159/000310616 · doi:10.1159/000310616
  112. Steinhorst, 1993, Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy, Invest Ophthalmol Vis Sci, 34, 1753
  113. Steinhorst, 1993, N,N-Dimethyladriamycin for treatment of experimental vitreoretinopathy, Exp Eye Res, 56, 489, 10.1006/exer.1993.1062 · doi:10.1006/exer.1993.1062
  114. Stolba, 1995, Use of perfluorocarbon liquids in proliferative vitreoretinopathy, Br J Ophthalmol, 79, 1106, 10.1136/bjo.79.12.1106 · doi:10.1136/bjo.79.12.1106
  115. Stout, 1996, Gene therapy for proliferative vitreoretinopathy, Exp Eye Res, 63, S12
  116. Tang, 1992, Lymphocytes, macrophages and HLA-DR expression in vitreal and epiretinal membranes of proliferative vitreoretinopathy. An immunohistochemical study, Ger J Ophthalmol, 1, 176
  117. Tano, 1980, Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide, Am J Ophthalmol, 90, 810, 10.1016/S0002-9394(14)75196-7 · DOI · Paper page
  118. Uram, 1994, Laser endoscope in the management of proliferative vitreoretinopathy, Ophthalmology, 101, 1404, 10.1016/S0161-6420(94)31157-2 · doi:10.1016/s0161-6420(94)31157-2
  119. Velikay, 1993, Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin, Am J Ophthalmol, 116, 565, 10.1016/S0002-9394(14)73197-6 · doi:10.1016/s0002-9394(14)73197-6
  120. Vidauri-Leal, 1984, Effect of vitreous on morphologic characteristics of retinal pigment epithelial cells. A new approach to the study of proliferative vitreoretinopathy, Arch Ophthalmol, 102, 1220, 10.1001/archopht.1984.01040030990033 · doi:10.1001/archopht.1984.01040030990033
  121. Ward, 1993, A comparison of 5-fluorouridine and 5-fluorouracil in an experimental model for the treatment of vitreoretinal scarring, Curr Eye Res, 12, 397, 10.3109/02713689309024621 · doi:10.3109/02713689309024621
  122. Weller, 1990, Proliferative vitreoretinopathy. Is it anything more than wound healing at the wrong place?, Int Ophthalmol, 14, 105, 10.1007/BF00154210 · DOI
  123. Wiedemann, 1992, Growth factors in retinal diseases, Surv Ophthalmol, 36, 373, 10.1016/0039-6257(92)90115-A · DOI · Paper page
  124. Wiedemann, 1989, A fluorescein angiographic study on patients with proliferative vitreoretinopathy treated by vitrectomy and intraocular daunomycin, Int Ophthalmol, 13, 211, 10.1007/BF02028213 · doi:10.1007/bf02028213
  125. Wiedemann, 1991, Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy, Graefes Arch Clin Exp Ophthalmol, 229, 150, 10.1007/BF00170548 · doi:10.1007/bf00170548
  126. Wiedemann, 1988, The pathophysiology of proliferative vitreoretinopathy, Acta Ophthalmol, 189, 3
  127. Wilkins, 1979, Wound healing, Ophthalmology, 86, 507, 10.1016/S0161-6420(79)35490-2 · doi:10.1016/s0161-6420(79)35490-2
  128. Williams, 1988, Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator, Arch Ophthalmol, 106, 1055, 10.1001/archopht.1988.01060140211025 · DOI
  129. Yang, 1992, Quantitative assessment of growth stimulating activity of the vitreous during PVR, Invest Ophthalmol Vis Sci, 33, 2436
  130. Yang, 1996, Inhibition of retinal pigment epithelial cell-induced tractional detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom, Invest Ophthalmol Vis Sci, 37, 843

Cited by

See all 409

Metadata

Authors
Pastor, J. C.
Venue
Survey of Ophthalmology
Publisher
Elsevier BV
Published
1998-07
Volume
43
Issue
1
Pages
3-18
ISSN
0039-6257 (ISSN-L)
DOI
10.1016/s0039-6257(98)00023-x
OpenAlex
W2114232337
Cited by
409
References
0
FWCI
3.27
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proliferative Vitreoretinopathy. https://app.cochat.ai/papers/10.1016/s0039-6257(98)00023-x
The paper
Pastor, J. C. (1998). Proliferative Vitreoretinopathy. Survey of Ophthalmology. https://doi.org/10.1016/s0039-6257(98)00023-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.